about
Split-intein mediated circular ligation used in the synthesis of cyclic peptide libraries in E. coli.Targeting Bacillus anthracis toxicity with a genetically selected inhibitor of the PA/CMG2 protein-protein interactionA bidirectional fluorescent two-hybrid system for monitoring protein-protein interactions.A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells.Peptides come round: using SICLOPPS libraries for early stage drug discovery.Methods for the creation of cyclic Peptide libraries for use in lead discovery.Traceless Production of Cyclic Peptide Libraries in E. coli.Intracellular Production of Cyclic Peptide Libraries with SICLOPPS.Reprogramming the Transcriptional Response to Hypoxia with a Chromosomally Encoded Cyclic Peptide HIF-1 Inhibitor.SICLOPPS cyclic peptide libraries in drug discovery.Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30Cytoplasmic tail of IL-13Ralpha2 regulates IL-4 signal transduction.Post-translational control of protein function with light using a LOV-intein fusion protein.Perenosins: a new class of anion transporter with anti-cancer activity.HIF-1 promotes the expression of its α-subunit via an epigenetically regulated transactivation loop.Transcription of click-linked DNA in human cells.The association of the cytoplasmic domains of interleukin 4 receptor alpha and interleukin 13 receptor alpha 2 regulates interleukin 4 signaling.Evaluating the role of phage-shock protein A in Burkholderia pseudomallei.Assessing the biocompatibility of click-linked DNA in Escherichia coli.Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction.Synthesis and biological evaluation of alpha- and gamma-carboxamide derivatives of 10-CF3CO-DDACTHF.Triggering apoptosis in cancer cells with an analogue of cribrostatin 6 that elevates intracellular ROS.Assembly of a biocompatible triazole-linked gene by one-pot click-DNA ligation.Stereocontrol by quaternary centres: a stereoselective synthesis of (-)-luminacin D.Advances at the intersection of chemical biology and medicinal chemistry.AMPK Activation via Modulation of De Novo Purine Biosynthesis with an Inhibitor of ATIC Homodimerization.A lanthipeptide library used to identify a protein-protein interaction inhibitor.A genetically selected cyclic peptide inhibitor of BCL6 homodimerization.Genetic selection of cyclic peptide Dam methyltransferase inhibitors.Fluorescent transmembrane anion transporters: shedding light on anionophoric activity in cellsSmall molecules in biologyModulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug ResistanceGenetically Encoded Cyclic Peptide Libraries: From Hit to Lead and BeyondInhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligase.Synthetic biologyDevelopment of a Cyclic Peptide Inhibitor of the p6/UEV Protein-Protein InteractionA cyclic peptide inhibitor of C-terminal binding protein dimerization links metabolism with mitotic fidelity in breast cancer cellsp53 is regulated by aerobic glycolysis in cancer cells by the CtBP family of NADH-dependent transcriptional regulatorsHypoxia Drives the Assembly of the Multi-Enzyme Purinosome Complex
P50
Q33286530-18E26888-9E4C-4367-A0E7-01E47D135B29Q33780004-F637C804-E9B4-40BE-A834-F212019F4DDAQ34395186-2059BFDB-F567-4D25-99C4-A95945E19E25Q34782024-09EC2C3F-6B3A-4C2F-A040-862E1102E229Q35209857-68C4E2F6-ADCF-49C7-B94E-146EEB975D0BQ35542409-E75C3E85-1785-4767-A857-481EB28EBFD5Q35973607-0353E8DA-D91F-480F-B370-ABF89A758F52Q36156152-228B8B11-AD2B-4E3F-B59F-4CBA62673987Q36225554-EF153036-E208-4A45-946D-520964479ABFQ36297067-E6558DF7-B05D-430B-B774-5E1B3D643D37Q37070609-11D7A79D-9CE8-4A42-B3F2-A3ACC15EF6CCQ37554641-0F60C4CC-BB1E-4D05-822E-84355B6F110CQ38789117-C7D17FB9-780D-4275-95BB-D73ACA5E0BDDQ38791794-9B365B83-F6C1-4CB6-A3A7-BBDA8751AFBFQ38968823-E7F9FD28-D38B-4341-B8A4-4640B285A1FEQ39031601-BB8056D3-3F0D-448B-8947-EDD409B83E21Q39093135-ADF84549-6468-460D-AB62-E7D7E3EEA704Q40997709-4993F308-AB13-455A-9CC5-ADC345F7A253Q41517731-EBA050FC-715F-4F1D-8F0F-A174E2E4A51CQ44447645-C0509F78-CE32-472F-96D6-8D38A5783ADBQ46453236-59AA5557-90F1-46DC-AE94-146E0A8FD4C4Q46479904-FE8DC974-2E47-4D78-9333-CF3C5A529DD7Q46897084-C93E9755-45B8-4D37-AC43-FCBA7739A444Q47913389-5EA3EC24-307C-4742-8E07-E134D41FA723Q48319675-2E7A1CD1-CDD9-41B3-B44E-94B52E237B4BQ50957175-73805AC4-418A-428E-8254-AFE00E853C9AQ52673136-B248E48C-A05A-47D7-A786-21944C2FF63DQ53078328-E6D6D6E5-9C80-492B-BD9C-042448EF87F4Q53555152-3B42E1C6-07A8-4F9C-A53E-70CA4887C539Q57375029-FF8ECD69-2480-4063-80BE-CFB9A6FF5B36Q57540695-7FE37CE1-C9F2-456E-B330-B7F027007429Q57806985-44A8E824-3BDC-45A2-B942-692859970C5BQ58582046-266D2E8D-C2CD-4138-BDCA-097BFC7604D0Q64927546-1D711299-1675-4460-8572-12EBFBC4B108Q82298856-FDBEB795-6733-416F-AF59-4F60F40FDBA6Q92615446-BF80A7C9-75E7-4822-838A-7BAB0194D9D0Q93202355-9747CDA1-D099-495E-801A-D455241E94A2Q94551720-96B57351-8AD5-4CB3-B160-5E80404BBFF7Q95320153-B1EEA77D-9BBC-4E1F-82E4-1FAB080EEAA8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ali Tavassoli
@ast
Ali Tavassoli
@en
Ali Tavassoli
@es
Ali Tavassoli
@nl
type
label
Ali Tavassoli
@ast
Ali Tavassoli
@en
Ali Tavassoli
@es
Ali Tavassoli
@nl
prefLabel
Ali Tavassoli
@ast
Ali Tavassoli
@en
Ali Tavassoli
@es
Ali Tavassoli
@nl
P106
P31
P496
0000-0002-7420-5063